Trade Sanctions and Publishing Sample Clauses

Trade Sanctions and Publishing. ASERS Publishing is committed to the principles of freedom of expression and we believe strongly in the international dimension of science. Sharing information about science and health improves lives and creates new insight and value. We acknowledge that governments have legitimate interests in promoting human rights, security and terrorism concerns, the rule of law, and preventing the proliferation of weapons of mass destruction. We are committed to finding a balance between these interests, which will sometimes involve challenging government over-reach or over-interpretation. Countries/Entities affected It is important to understand that several countries maintain lists of individuals and entities with whom it is illegal to conduct business, and more than one law can apply to an individual transaction. Additionally, several countries also implement controls on the export of ‘dual use’ items (goods, services and technologies): these are items which have commercial but also potentially military or proliferation applications, even if not obvious, for instance nuclear related software like MCNP-derivate codes and ORIGEN code. If you are a customer or an author from one of the following countries, you might be affected by these trade sanctions and export control laws: Iran, Cuba, Sudan, Burma, Syria or Crimea. Further, if you have been identified by such governments as a person or an entity involved in some of the activities noted above, you may also be affected by such laws. Information Materials Exemption/General Publishing License re US imposed Embargoes The US sanctions laws include an Information Materials Exemption and a General License for Publishing. Such exemption and license permits a broad range of publishing activities for academic researchers for book and journal publishing, and also permits the sale of such material into countries where such US sanctions apply. Certain services such as training are not allowed, and software may also have some restrictions. The exemption does not apply to, and therefore an embargo applies to, individuals or legal entities specifically identified (by either the US or the EU) as being involved in security or rights issues (‘Specially Designated Nationals’). Individuals employed by a Specially Designated National would fall under this embargo, unless the individual is acting, and e.g. submits a manuscript on its own behalf and not on behalf of the Specially Designated National. If you are an author located in a sanc...
AutoNDA by SimpleDocs
Trade Sanctions and Publishing. ASERS Publishing is committed to the principles of freedom of expression, and we believe strongly in the international dimension of science. Sharing information about science and health improves lives and creates new insight and value. We acknowledge that governments have legitimate interests in promoting human rights, security and terrorism concerns, the rule of law, and preventing the proliferation of weapons of mass destruction. We are committed to finding a balance between these interests, which will sometimes involve challenging government over-reach or over-interpretation.

Related to Trade Sanctions and Publishing

  • PUBLIC RELATIONS AND PUBLICITY 43.1 The Provider must not by itself, its employees or agents and procure that its Sub-Contractors must:

  • RESEARCH AND PUBLICATION 34 CONTRACTOR shall not utilize information and/or data received from COUNTY, or arising out 35 of, or developed, as a result of this Agreement for the purpose of personal or professional research, or 36 for publication. 37 //

  • Goodwill and Publicity Neither Party shall use any name, trade name, service xxxx or trademark of the other Party in any promotional or advertising material without the prior written consent of such other Party. The Parties shall coordinate and cooperate with each other when making public announcements related to the execution and existence of this Agreement, and each Party shall have the right to promptly review, comment upon and approve any publicity materials, press releases or other public statements by the other Party that refer to, or that describe any aspect of, this Agreement. Neither Party shall make any press release or public announcement of the specific terms of this Agreement (except for filings or other statements or releases as may be required by applicable law) without the specific prior written consent of the other Party. Without limiting the generality of the foregoing, all public statements must accurately reflect the rights and obligations of the Parties under this Agreement, including the ownership of Environmental Attributes and Environmental Incentives and any related reporting rights.

  • Confidentiality and Publication 4.1 Any information which is disclosed by Xxxxxxx to the Recipient or the Recipient Scientist in connection with the Research Project and/or the Original Material ("Confidential Information") shall remain confidential to, and the property of, Xxxxxxx. The Recipient and the Recipient Scientist hereby agree that for so long as the Confidential Information remains confidential in nature, the Recipient and the Recipient Scientist shall keep the Confidential Information secret. Upon request, the Recipient shall inform Xxxxxxx and the Xxxxxxx Scientist on the status of its research. The Recipient Scientist will inform Xxxxxxx at least 30 days in advance of the submission of any potential publication of any form (abstract, manuscript, review, oral presentation, patent application etc.) related to the use of the Material and/or Modifications or the Research Project. If Xxxxxxx believes that co-authorship is required, Xxxxxxx and Recipient Scientist shall discuss in good faith co-authorship of all oral or written publications. If Xxxxxxx does not require co-authorship, the Recipient Scientist shall acknowledge Xxxxxxx and Xxxxxxx Scientist as the source of the Material in all publications reporting use of the Material and/or Modifications. The Recipient Scientist shall reference the following publication(s) in all publications reporting the use of the Material: Xxxxxx J; Xxxxxxx L, Xxxxxxxx H, Xxxxxxxxxxxx S, Xxxxxxxx E, Xxxxxxxx D, Xxxxxxx G (1991). "Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis." EMBO J.; 10(13); 4025-31. If Xxxxxxx believes that the publication contains any Confidential Information it shall so notify the Recipient Scientist. Recipient shall proceed to implement the amendments requested by Xxxxxxx including the removal of any Confidential Information, with every effort made so that such amendments made will not compromise the timing nor the scientific value of the publication or presentation.

  • Advertising and Publicity No Credit Party shall issue or disseminate to the public (by advertisement, including without limitation any “tombstone” advertisement, press release or otherwise), submit for publication or otherwise cause or seek to publish any information describing the credit or other financial accommodations made available by the Lenders pursuant to this Agreement and the other Loan Documents without the prior written consent of the Administrative Agent. Nothing in the foregoing shall be construed to prohibit any Credit Party from making any submission or filing which it is required to make by applicable law or pursuant to judicial process; provided, that, (i) such filing or submission shall contain only such information as is necessary to comply with applicable law or judicial process and (ii) unless specifically prohibited by applicable law or court order, the Borrower shall promptly notify the Administrative Agent of the requirement to make such submission or filing and provide the Administrative Agent with a copy thereof.

  • References to Statutes, Public Acts, Regulations, Codes and Executive Orders All references in this Contract to any statute, public act, regulation, code or executive order shall mean such statute, public act, regulation, code or executive order, respectively, as it has been amended, replaced or superseded at any time. Notwithstanding any language in this Contract that relates to such statute, public act, regulation, code or executive order, and notwithstanding a lack of a formal amendment to this Contract, this Contract shall always be read and interpreted as if it contained the most current and applicable wording and requirements of such statute, public act, regulation, code or executive order as if their most current language had been used in and requirements incorporated into this Contract at the time of its execution.

  • CONFIDENTIALITY AND PUBLICITY 14.1. All information which is disclosed by one party (“Disclosing Party”) to the other (“Recipient”) in connection with this Agreement, or acquired in the course of performance of this Agreement, shall be deemed confidential and proprietary to the Disclosing Party and subject to this Agreement, such information including but not limited to, orders for services, usage information in any form, and CPNI as that term is defined by the Act and the rules and regulations of the FCC (“Confidential and/or Proprietary Information”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!